Financing channel feed – Endpoints News

Financing channel feed

Can the antibody-drug conjugate model work for NK cells? Acepodia loads up with another $109M to find out

4 years ago

Looking to run with Big Pharma, a radiopharma startup with backing from Atlas, RA thinks it has the chops to compete

4 years ago

Apollo Health Ventures pumps another $180M into the burgeoning race to slow aging

4 years ago

After Big Pharma sparked interest in the US, Ablaze looks to bring radiopharmaceuticals overseas

4 years ago

China’s top mRNA contender is ready to go. And SoftBank just led a cash infusion pushing it over the $1B line

4 years ago

European investors pour $156M to beat Bluestone, Third Rock and RA Capital in multibillion-dollar race to the clinic

4 years ago

HotSpot gets hotter with $100M raise to push toward clinic

4 years ago

BeiGene gets the ball rolling on its 3rd IPO — and this one is expected to fetch $3B

4 years ago

A fledgling transpacific biotech grabs a launch round to dive into oncology and autoimmune research

4 years ago

BioCryst gets massive cash infusion to the tune of $350M, thanks to old and new investors

4 years ago

Benchling adds another megaround into the fold, looking even more unicorn-y as a possible IPO approaches

4 years ago

Industry gets the edge: Medicare drug price negotiations will only cost biopharma 10 drugs over the next 30 years

4 years ago

Months after massive Ipsen deal, BAKX Therapeutics nets more cash for its 'Thelma and Louise' approach to cancer cell death

4 years ago

BridgeBio borrows $750M ahead of key PhIII readout, as it looks to wrap up buzzy 2021

4 years ago

An RA-backed startup 'ATACs' a novel challenge, looking to spur protein degradation outside the cell

4 years ago

Flagship's machine learning startup Generate bags $370M in latest round with plans for a big hiring spree

4 years ago

In a surprise move, Flagship's Valo Health and Khosla Ventures SPAC call off merger

4 years ago

CBC Group establishes new fund to meet China's booming life sciences real estate demand

4 years ago

Backed by Sean Harper and Beth Seidenberg, an LA biotech scores a massive $250M crossover ahead of 2022 IPO

4 years ago

Former Blueprint vets take their new biotech out of stealth, with STAT3 in their sights

4 years ago

Acrivon bags a megaround to advance an old Eli Lilly program, 5 months after launch. Is an IPO far behind?

4 years ago

Bono invests in biotech? Peptide player is headed to the US — with celebrity investors backing its move

4 years ago

Genenta is attempting a rare biotech leap from Milan to Wall Street

4 years ago

A better way to control where drugs go? Investors bet on small biotech's mission to 'click' together cancer meds

4 years ago

First page Previous page 62 63 646566 67 68 Next page Last page